Symptom control in patients with locally recurrent rectal cancer.

  • Thomas J. Miner
  • , David P. Jaques
  • , Philip B. Paty
  • , Jose G. Guillem
  • , W. Douglas Wong

Research output: Contribution to journalArticlepeer-review

78 Scopus citations

Abstract

BACKGROUND: Although resection of locally recurrent rectal cancer has been associated with improved survival, clinical outcomes after such repeat surgery have been incompletely characterized. METHODS: From 1997 to 1999, 105 consecutive patients requiring repeat surgery for locally recurrent rectal cancer were identified. Patients were observed for a minimum of 2 years or until death. RESULTS: An operation was performed with palliative intent in 23% of patients. Before repeat surgery, 79% of the palliative-intent patients had symptoms: 21% bleeding, 42% obstruction, and 21% pain. After repeat surgery with palliative intent, improvement was noted in 40% with bleeding, 70% with obstruction, and 20% with pain. Additional or recurrent symptoms were noted in 87% during follow-up. Seventy-seven percent of patients had an operation with nonpalliative intent. Before repeat surgery, 57% of nonpalliative patients had symptoms, with 32% experiencing bleeding, 11% obstruction, and 19% pain. After repeat surgery with nonpalliative intent, initial improvement was noted in 88% with bleeding, 78% with obstruction, and 40% with pain. During follow-up, symptoms arose in 37% of the initially asymptomatic patients, and additional or recurrent symptoms were seen in 63% of those previously symptomatic. CONCLUSIONS: Although symptomatic relief is associated with repeat surgery, the recurrence or development of alternate symptoms makes a completely asymptomatic clinical course uncommon.

Original languageEnglish (US)
Pages (from-to)72-79
Number of pages8
JournalAnnals of Surgical Oncology
Volume10
Issue number1
DOIs
StatePublished - 2003

All Science Journal Classification (ASJC) codes

  • Surgery
  • Oncology

Fingerprint

Dive into the research topics of 'Symptom control in patients with locally recurrent rectal cancer.'. Together they form a unique fingerprint.

Cite this